Thread regarding Medtronic Inc. layoffs

60s today most likely

Thank the board!

by
| 1721 views | | 11 replies (last October 27, 2023) | Reply
Post ID: @OP+1p4OtmYM

11 replies (most recent on top)

we have broken the threshold! congrats Geoff!

by
| | Reply
Post ID: @ekbi+1p4OtmYM

He has a short one alright @dsyi+1p4OtmYM

by
| | Reply
Post ID: @dnfp+1p4OtmYM

$133 to $70 in 2 years. How on earth are these clowns still running the show?!

Earnings have been leaked, no way the stock falls this much in a month without Wall Street being tipped off.

I wouldn’t be surprised if GM has a short position.

by
| | Reply
Post ID: @dsyi+1p4OtmYM

60s tomorrow! Thank the board!

by
| | Reply
Post ID: @djrt+1p4OtmYM

So let me get this straight. The stock will drop to the 60s, there will be a RIF, and GM and his buddies will get a fat bonus.

That aint right

by
| | Reply
Post ID: @duul+1p4OtmYM

Congratulations on another 1% loss! Almost to 60s

by
| | Reply
Post ID: @chlx+1p4OtmYM

60s this week

by
| | Reply
Post ID: @chsk+1p4OtmYM

If they announce CEO , CFO, CIO’s departure, the stock may go up to triple digits. But looking at the MDT weekly option price, that does not seem likely .

by
| | Reply
Post ID: @adez+1p4OtmYM

@7ibq+1p4OtmYM

It will be tough to get to triple digits in the near future. Geoff and Karen have little credibility with Wall Street, which can limit any stock gains in the near future. Others here can correct me if I'm wrong, but the three major projects in the pipeline that were supposed to drive growth were the new diabetes pump, RDN and the Hugo robot.

The new diabetes pump (MiniMed 780G) was approved back in April, but I'm not sure what kind of financial impact it has had. Renal denervation was supposed to be a brand new market and MDT has invested $2-3B into it since acquiring Ardian for $800M back in 2010. However, when it went to the FDA panel back in August the panel did not recommend approving it and said the risks outweighed the benefits. It's important to note that Recor, the other company looking into renal denervation, received an approval recommendation from that same panel. It's still possible that MDT receives FDA approval for RDN, but I would assume that reimbursement will be a huge challenge.

I don't know the status of Hugo in terms of expected timing around FDA approval. A Da Vinci robot costs around $2 million and has a long sales cycle. Even at a 20% discount to Da Vinci, most hospitals don't have those kind of capital dollars laying around for a new robot that is similar to what they already have. I'm not sure what kind of growth MDT has promised Wall Street from Hugo, but it's going to take flawless execution to have any meaningful marketshare gains from Intuitive.

tldr: It's gonna be really hard to get back to the 100's without a reverse stock split.

by
| | Reply
Post ID: @8rjd+1p4OtmYM

I left MDT back in April during the RIF/VERP. As much as it amuses me to peruse this site and see that the chaos and dysfunction continues, I also for selfish reasons would like to see some good news that will move the needle on MDT stock. I still have some skin in the game with unexercised stock options that expire in about 1 year. Still kicking myself for not selling when the stock was around 125 a few years back. Is there anything in the pipeline that will get this turkey of a stock back up to triple digits in the foreseeable future?

by
| | Reply
Post ID: @7ibq+1p4OtmYM

Woohoo! It was great while it lasted

by
| | Reply
Post ID: @3tbv+1p4OtmYM

Post a reply

: